NOS2 and pulmonary fibrosis: Recent research suggested that thymoquinone-PLGA-PVA nanoparticles [29], amitriptyline [30], and zingerone [31] could reduce the expression of iNOS to ameliorate bleomycin-induced pulmonary fibrosis.